Treatment Strategies in HER2+ Colorectal Cancer: An Expert Case-Based Discussion

home / around-the-practice / treatment-strategies-in-her2-colorectal-cancer-an-expert-case-based-discussion

A panel of experts on HER2+ colorectal cancer present patient cases and discuss clinical trial data and the evolving treatment landscape.

Experts on colorectal cancer

EP. 1: Patient Profile: A 46-Year-Old Woman With HER2+ Metastatic Colorectal Cancer

Cathy Eng, MD;Suneel D. Kamath, MD;Michael Foote, MD;Arvind Dasari, MD, MS;Aparna Raj Parikh, MD, MS
April 24th 2023

A panel of expert oncologists present the case of a 46-year-old woman with HER2+ metastatic colorectal cancer, who is treated with tucatinib in the second-line setting.

Experts on colorectal cancer

EP. 2: Overview of HER2+ Metastatic Colorectal Cancer

Cathy Eng, MD;Suneel D. Kamath, MD;Michael Foote, MD;Arvind Dasari, MD, MS;Aparna Raj Parikh, MD, MS
April 24th 2023

Expert oncologists discuss the landscape surrounding HER2+ metastatic CRC, including recommendations for biomarker testing and an overview of scoring criteria.

Experts on colorectal cancer

EP. 3: Treatment Landscape for HER2+ Metastatic Colorectal Cancer

Cathy Eng, MD;Suneel D. Kamath, MD;Michael Foote, MD;Arvind Dasari, MD, MS;Aparna Raj Parikh, MD, MS
May 1st 2023

An overview of the treatment landscape for HER2+ metastatic colorectal cancer and recent updates to the NCCN Guidelines.

Experts on colorectal cancer

EP. 4: MOUNTAINEER: Tucatinib Plus Trastuzumab in HER2+ Metastatic Colorectal Cancer

Cathy Eng, MD;Suneel D. Kamath, MD;Michael Foote, MD;Arvind Dasari, MD, MS;Aparna Raj Parikh, MD, MS
May 1st 2023

Experts on HER2+ metastatic colorectal cancer review the MOUNTAINEER study on tucatinib plus trastuzumab.

Experts on colorectal cancer

EP. 5: Patient Profile: A 47-Year-Old Woman With HER2+ CRC and Early Disease Progression

Cathy Eng, MD;Suneel D. Kamath, MD;Michael Foote, MD;Arvind Dasari, MD, MS;Aparna Raj Parikh, MD, MS
May 8th 2023

Expert oncologists present the case of a 47-year-old woman with colorectal cancer and early disease progression, and discuss treatment options with the ongoing MOUNTAINEER-03 study.

Arvind Dasari, MD, MS, an expert on colorectal cancer

EP. 6: PARADIGM Trial: Recent Data on EGFR-Targeting Therapy for mCRC

Cathy Eng, MD;Suneel D. Kamath, MD;Michael Foote, MD;Arvind Dasari, MD, MS;Aparna Raj Parikh, MD, MS
May 8th 2023

Arvind Dasari, MD, MS, reviews the PARADIGM study on EGFR-targeting therapy in metastatic colorectal cancer.

Arvind Dasari, MD, MS, an expert on colorectal cancer

EP. 7: Metastatic CRC: Role of ctDNA in Treatment Selection

Cathy Eng, MD;Suneel D. Kamath, MD;Michael Foote, MD;Arvind Dasari, MD, MS;Aparna Raj Parikh, MD, MS
May 15th 2023

Insights on the role of circulating tumor DNA in treatment selection for patients with metastatic colorectal cancer.

Experts on colorectal cancer

EP. 8: Patient Profile: A 40-Year-Old Woman With Colorectal Cancer

Cathy Eng, MD;Suneel D. Kamath, MD;Michael Foote, MD;Arvind Dasari, MD, MS;Aparna Raj Parikh, MD, MS
May 15th 2023

Experts on colorectal cancer present the case of a 40-year-old woman with CRC, who receives later-line treatment with trastuzumab deruxtecan, and share their initial thoughts.

Experts on colorectal cancer

EP. 9: T-DXd in Patients With HER2+ Metastatic Colorectal Cancer

Cathy Eng, MD;Suneel D. Kamath, MD;Michael Foote, MD;Arvind Dasari, MD, MS;Aparna Raj Parikh, MD, MS
May 22nd 2023

A comprehensive overview of trastuzumab deruxtecan (T-DXd) as a treatment for patients with HER2+ metastatic colorectal cancer.

Experts on colorectal cancer

EP. 10: Colorectal Cancer: Insights on ctDNA and Retesting for HER2 Expression

Cathy Eng, MD;Suneel D. Kamath, MD;Michael Foote, MD;Arvind Dasari, MD, MS;Aparna Raj Parikh, MD, MS
May 22nd 2023

A panel of experts discuss the role of ctDNA and their practices for retesting HER2 expression to guide treatment for colorectal cancer.

Arvind Dasari, MD, MS, an expert on colorectal cancer

EP. 11: SUNLIGHT and FRESCO-2 Trials in Refractory Colorectal Cancer

Cathy Eng, MD;Suneel D. Kamath, MD;Michael Foote, MD;Arvind Dasari, MD, MS;Aparna Raj Parikh, MD, MS
May 29th 2023

An overview of the SUNLIGHT and FRESCO-2 studies in the refractory colorectal cancer space.

Experts on colorectal cancer

EP. 12: Trials Focused on ctDNA in Colorectal Cancer

Cathy Eng, MD;Suneel D. Kamath, MD;Michael Foote, MD;Arvind Dasari, MD, MS;Aparna Raj Parikh, MD, MS
May 29th 2023

An expert panel discusses clinical trials focused on circulating tumor DNA in guiding treatment selection in colorectal cancer.

Experts on colorectal cancer

EP. 13: Unmet Needs and Future Perspectives on Colorectal Cancer

Cathy Eng, MD;Suneel D. Kamath, MD;Michael Foote, MD;Arvind Dasari, MD, MS;Aparna Raj Parikh, MD, MS
June 5th 2023

A panel of expert oncologists offer closing thoughts on the future treatment landscape and unmet needs in colorectal cancer.

Recap: Treatment Sequencing and Testing Strategies in HER2+ Colorectal Cancer

EP. 14: Recap: Treatment Sequencing and Testing Strategies in HER2+ Colorectal Cancer

ONCOLOGY Staff
June 21st 2023

An expert panel reviews the management of toxicities, genetic testing, and other topics in colorectal cancer.